These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 15358619

  • 21. Intermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomes.
    Neumann D, Wikström L, Watowich SS, Lodish HF.
    J Biol Chem; 1993 Jun 25; 268(18):13639-49. PubMed ID: 8514796
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Ubiquitination regulates the internalization, endolysosomal sorting, and signaling of the erythropoietin receptor.
    Bulut GB, Sulahian R, Ma Y, Chi NW, Huang LJ.
    J Biol Chem; 2011 Feb 25; 286(8):6449-57. PubMed ID: 21183685
    [Abstract] [Full Text] [Related]

  • 25. The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation.
    Sawyer ST, Hankins WD.
    Proc Natl Acad Sci U S A; 1993 Jul 15; 90(14):6849-53. PubMed ID: 8341708
    [Abstract] [Full Text] [Related]

  • 26. Activation of the erythropoietin receptor in human skeletal muscle.
    Rundqvist H, Rullman E, Sundberg CJ, Fischer H, Eisleitner K, Ståhlberg M, Sundblad P, Jansson E, Gustafsson T.
    Eur J Endocrinol; 2009 Sep 15; 161(3):427-34. PubMed ID: 19515792
    [Abstract] [Full Text] [Related]

  • 27. Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia.
    Sulahian R, Cleaver O, Huang LJ.
    Blood; 2009 May 21; 113(21):5287-97. PubMed ID: 19336760
    [Abstract] [Full Text] [Related]

  • 28. Erythropoietin receptors associate with a ubiquitin ligase, p33RUL, and require its activity for erythropoietin-induced proliferation.
    Friedman AD, Nimbalkar D, Quelle FW.
    J Biol Chem; 2003 Jul 18; 278(29):26851-61. PubMed ID: 12746455
    [Abstract] [Full Text] [Related]

  • 29. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
    Shi J, Yuan B, Hu W, Lodish H.
    Exp Hematol; 2016 Nov 18; 44(11):1044-1058.e5. PubMed ID: 27473563
    [Abstract] [Full Text] [Related]

  • 30. Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
    Rainville N, Jachimowicz E, Wojchowski DM.
    Expert Opin Ther Targets; 2016 Nov 18; 20(3):287-301. PubMed ID: 26419263
    [Abstract] [Full Text] [Related]

  • 31. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
    Um M, Gross AW, Lodish HF.
    Cell Signal; 2007 Mar 18; 19(3):634-45. PubMed ID: 17045782
    [Abstract] [Full Text] [Related]

  • 32. Mutations in the WSAWSE and cytosolic domains of the erythropoietin receptor affect signal transduction and ligand binding and internalization.
    Quelle DE, Quelle FW, Wojchowski DM.
    Mol Cell Biol; 1992 Oct 18; 12(10):4553-61. PubMed ID: 1406645
    [Abstract] [Full Text] [Related]

  • 33. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model.
    Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, Priller J, Dirnagl U, Meisel A.
    J Neurosci; 2002 Dec 01; 22(23):10291-301. PubMed ID: 12451129
    [Abstract] [Full Text] [Related]

  • 34. Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms.
    Neumann D, Yuk MH, Lodish HF, Lederkremer GZ.
    Biochem J; 1996 Jan 15; 313 ( Pt 2)(Pt 2):391-9. PubMed ID: 8573070
    [Abstract] [Full Text] [Related]

  • 35. JAK kinases control IL-5 receptor ubiquitination, degradation, and internalization.
    Martinez-Moczygemba M, Huston DP, Lei JT.
    J Leukoc Biol; 2007 Apr 15; 81(4):1137-48. PubMed ID: 17227823
    [Abstract] [Full Text] [Related]

  • 36. Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells.
    Fukumoto T, Kubota Y, Kitanaka A, Yamaoka G, Ohara-Waki F, Imataki O, Ohnishi H, Ishida T, Tanaka T.
    Cell Signal; 2009 Dec 15; 21(12):1775-83. PubMed ID: 19665053
    [Abstract] [Full Text] [Related]

  • 37. Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment.
    Xie Z, Chen F, Wu X, Zhuang C, Zhu J, Wang J, Ji H, Wang Y, Hua X.
    Curr Eye Res; 2012 Feb 15; 37(2):138-44. PubMed ID: 22251399
    [Abstract] [Full Text] [Related]

  • 38. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
    Bose C, Udupa KB.
    Am J Physiol Cell Physiol; 2008 Aug 15; 295(2):C394-405. PubMed ID: 18550701
    [Abstract] [Full Text] [Related]

  • 39. The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells--signals emanating from the erythropoietin receptor.
    Klingmüller U.
    Eur J Biochem; 1997 Nov 01; 249(3):637-47. PubMed ID: 9395308
    [Abstract] [Full Text] [Related]

  • 40. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface.
    Migliaccio AR, Migliaccio G, D'Andrea A, Baiocchi M, Crotta S, Nicolis S, Ottolenghi S, Adamson JW.
    Proc Natl Acad Sci U S A; 1991 Dec 15; 88(24):11086-90. PubMed ID: 1722318
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.